-
What's new
- All What's new
-
European
- What's new - All
- <hr>
- What's new - last 24 hrs
- What's new - last 7 days
- What's new - last 30 days
- <hr>
- New EU Legislation
- European Commission
- European Banking Authority
- European Securities and Markets Authority
- European Insurance and Occupational Pensions Authority
- <hr>
- Consultations and similar
- Commentaries
- <hr>
- Downloads and Exports
- Latest news by Topics
-
International
- What's new - All
- <hr>
- What's new - last 24 hrs
- What's new - last 7 days
- What's new - last 30 days
- <hr>
- Bank for International Settlements
- Basel Committee on Banking Supervision
- Egmont Group
- International Association of Insurance Supervisors
- International Monetary Fund
- <hr>
- Consultations and similar
- Commentaries
- <hr>
- Downloads and Exports
- Latest news by Topics
- Downloads and Exports
- Legislation
- Organisations
-
Commentaries
- Consultations
- Sanctioned regimes
- IFRSs
- Regulatory calendar
- Quicklinks
-
More
Table of Contents
Document Overview
AI Disclaimer
Please note that AI-generated content should not be considered legal advice. Users are encouraged to consult with qualified professionals or legal advisors where specific legal guidance is required.
We are committed to transparency and responsible use of AI in a way that supports, but never replaces, human expertise.
If you have any questions or concerns about the use of AI on our platform, please feel free to contact us.
1.7
(updated 30 December 2024)
The systems and controls that firms should put in place to ensure their individual and business- wide risk assessments remain up to date should include:
a) Setting a date for each calendar year on which the next business-wide risk assessment update will take place, and setting a date on a risk sensitive basis for the individual risk assessment to ensure new or emerging risks are included.
b) Where the firm becomes aware before that date that a new ML/TF risk has emerged, or an existing one has increased, this should be reflected in their individual and business-wide risk assessments as soon as possible; and
c) Carefully recording issues throughout the relevant period that could have a bearing on risk assessments, such as internal suspicious transaction reports, compliance failures and intelligence from front office staff.
d) Where the firm is launching new products, services, or business practices, or significantly changing them, including where it introduces a new delivery channel, or adopts an innovative technology as part of its AML/CFT systems and controls framework, it should assess the ML/TF risk exposure prior to the launch of these products, services or business practices. Where these products, services or business practices have a significant impact on the firm's ML/TF risk exposure, the firm should reflect this assessment in its business-wide risk assessment carried out in accordance with Article 8(2) of Directive (EU) 2015/849 and its policies and procedures.